Whether a particular drug is branded or generic, it’s efficacy and safety profile should be the same. Often with the intention to reduce costs of medicines, less ethical means are taken to that end. If drug regulation is poor, unethical businessmen will stop at nothing to increase their profit margins. Our focus should not only be in reducing costs of drugs but more on ensuring that quality and reliable safe drugs reach the end consumers-the patients.
Vaccines are tough business. From all the decades of collective knowledge in vaccine development we have, it is very rare that we will get a successful vaccine for any disease. Vaccine development takes years and for good reason.